首页> 外文期刊>Evolutionary Bioinformatics >Identification of Metastasis-Associated Genes in Triple-Negative Breast Cancer Using Weighted Gene Co-expression Network Analysis
【24h】

Identification of Metastasis-Associated Genes in Triple-Negative Breast Cancer Using Weighted Gene Co-expression Network Analysis

机译:用加权基因共表达网络分析鉴定三阴性乳腺癌中转移相关基因的鉴定

获取原文
           

摘要

Triple-negative breast cancer (TNBC) is the most aggressive and fatal sub-type of breast cancer. This study aimed to identify metastasis-associated genes that could serve as biomarkers for TNBC diagnosis and prognosis. RNA-seq data and clinical information on TNBC from the Cancer Genome Atlas were used to conduct analyses. Expression data were used to establish co-expression modules using average linkage hierarchical clustering. We used weighted gene co-expression network analysis to explore the associations between gene sets and clinical features and to identify metastasis-associated candidate biomarkers. The K-M plotter website was used to explore the association between the expression of candidate biomarkers and patient survival. In addition, receiver operating characteristic curve analysis was used to illustrate the diagnostic performance of candidate genes. The pale turquoise module was significantly associated with the occurrence of metastasis. In this module, 64 genes were identified, and its functional enrichment analysis revealed that they were mainly associated with transcriptional misregulation in cancer, microRNAs in cancer, and negative regulation of angiogenesis. Further, 4 genes, IGSF10, RUNX1T1, XIST , and TSHZ2 , which were negatively associated with relapse-free survival and have seldom been reported before in TNBC, were selected. In addition, the mRNA expression levels of the 4 candidate genes were significantly lower in TNBC tumor tissues compared with healthy tissues. Based on the K-M plotter, these 4 genes were correlated with poor prognosis of TNBC. The area under the curve of IGSF10, RUNX1T1, TSHZ2 , and XIST was 0.918, 0.957, 0.977, and 0.749. These findings provide new insight into TNBC metastasis. IGSF10, RUNX1T1, TSHZ2 , and XIST could be used as candidate biomarkers for the diagnosis and prognosis of TNBC metastasis.
机译:三阴性乳腺癌(TNBC)是最具侵略性和致命的乳腺癌。本研究旨在鉴定转移相关基因,可作为TNBC诊断和预后的生物标志物。 RNA-SEQ数据和来自癌症基因组Atlas的TNBC的临床信息用于进行分析。表达数据用于使用平均链接分层聚类来建立共表达模块。我们使用加权基因共表达网络分析来探讨基因集和临床特征之间的关联,并鉴定转移相关的候选生物标志物。 K-M绘图仪网站用于探讨候选生物标志物和患者存活的表达之间的关联。此外,使用接收器操作特征曲线分析来说明候选基因的诊断性能。浅绿松石模块与转移的发生显着相关。在该模块中,确定了64个基因,其功能性富集分析表明,它们主要与癌症中的转录误解相关,癌症中的微大罗氏和血管生成的负调节。此外,选择了与无复发存活率产生负面相关的4个基因,IGSF10,Runx1T1,XIST和TSHZ2,并且在TNBC之前已经报告过。此外,与健康组织相比,TNBC肿瘤组织中4个候选基因的mRNA表达水平显着降低。基于K-M绘图仪,这些4基因与TNBC的预后不良相关。 IGSF10,RunX1T1,TSHZ2和XIST曲线下的区域为0.918,0.957,0.977和0.749。这些调查结果为TNBC转移提供了新的洞察力。 IGSF10,RunX1T1,TSHZ2和XIST可以用作候选生物标志物,用于TNBC转移的诊断和预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号